Here Are 6 Reasons Why the Market Is Getting Injective (INJ) Wrong

Injective has had a mix of good and bad news in recent days, but the bigger picture is starting to stand out.

On April 4, Agora shut down its AUSD stablecoin on Injective, forcing users to redeem and causing some short-term liquidity concerns. 

A day earlier, Bithumb paused Injective (INJ) deposits to support a network upgrade, which is a normal step but still added some temporary friction.

However, something bigger happened. Circle launched native USDC on Injective, opening the door for deeper liquidity and more institutional activity on the network.

So while the headlines look mixed, there’s a deeper story building underneath. And that’s where things get interesting.

Native EVM Changes Everything

Injective now supports a native EVM alongside its Cosmos setup. This means Ethereum developers can build directly on Injective without needing complicated bridges. It makes the network more flexible and opens the door for more apps to launch easily.

AI Trading Is Already Here

One of the most unique parts of Injective right now is how it’s mixing AI with trading. With the new MCP Server and Anthropic integration, users can interact with the market using simple language while AI handles execution. That’s a completely different experience from traditional trading platforms.

USDC Brings Serious Liquidity

The arrival of native USDC is a big deal. With billions already in circulation globally, this move could pull more capital into Injective. It also makes the network more useful for payments, trading, and DeFi activity.

Cross-Chain Access Is Expanding Fast

Injective (INJ) is becoming easier to access from other blockchains. With Stargate expanding to the network, users can now move assets from dozens of chains. This reduces fragmentation and makes liquidity easier to manage.

The Supply Squeeze Is Real

Injective has a built-in system that constantly reduces supply. A large part of fees is used to buy back and burn INJ every week. With a fixed supply and no new emissions, this creates steady pressure that could matter more over time.

Read Also: Gold and Silver Alert: $40 Trillion Debt Forces Fed to Print – Hard Assets Are the Only Escape

Institutional Attention Is Growing

Injective is also starting to attract attention at a higher level. Events like the upcoming Injective Summit in Washington, D.C. are bringing together finance, policy, and crypto players. That kind of exposure can shape how institutions view the network going forward.

So Why Is INJ Price Still $2.80?

INJ is sitting around $2.80, and the price hasn’t fully caught up with what’s happening behind the scenes. Some of the recent negative headlines may be holding it back in the short term.

But when you zoom out, the fundamentals look stronger than the price suggests. The real question is whether the market starts to catch on, or keeps sleeping on it.

Subscribe to our YouTube channel for daily crypto updates, market insights, and expert analysis.

The post Here Are 6 Reasons Why the Market Is Getting Injective (INJ) Wrong appeared first on CaptainAltcoin.